Synopsis
Synopsis
0
KDMF
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Biquinate
2. Bisulfate, Quinine
3. Hydrochloride, Quinine
4. Legatrim
5. Myoquin
6. Quinamm
7. Quinbisan
8. Quinbisul
9. Quindan
10. Quinimax
11. Quinine
12. Quinine Bisulfate
13. Quinine Lafran
14. Quinine Sulfate
15. Quinine Sulphate
16. Quinine-odan
17. Quinoctal
18. Quinson
19. Quinsul
20. Strema
21. Sulfate, Quinine
22. Sulphate, Quinine
23. Surquina
1. Quinine Hcl
2. 130-89-2
3. Quinine Muriate
4. Chinimetten
5. Quinine Monohydrochloride
6. Fema No. 2976
7. Ccris 2002
8. Einecs 205-001-1
9. 7549-43-1
10. 7cs0wno31m
11. Anhydrous Quinine Hydrochloride
12. Quinine Hydrochloride Anhydrous
13. Ai3-62121
14. Quinine, Hydrochloride (2:1)
15. Quinine Hydrochloride Dihydrate
16. (r)-[(2s,4s,5r)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol;hydrochloride
17. Chininum Muriaticum
18. Quinine Chloride
19. Quinine Hydrochloride Hydrate
20. 6119-47-7
21. Cinchonan-9-ol, 6'-methoxy-, Hydrochloride (1:1), (8alpha,9r)-
22. (r)-(6-methoxyquinolin-4-yl)((1s,2s,4s,5r)-5-vinylquinuclidin-2-yl)methanol Hydrochloride
23. 30860-23-2
24. Chinine Hydrochloride
25. Quinine, Hydrochloride
26. Fema No. 2976, Dihydrate-
27. Einecs 231-437-7
28. Unii-7cs0wno31m
29. Quinine, Monohydrochloride
30. Quininehcl
31. Quinini Hydrochloridum
32. (8alpha,9r)-6'-methoxycinchonan-9-ol Monohydrochloride
33. 6'-methoxycinchonan-9-ol Monohydrochloride, (8alpha,9r)-
34. Cinchonan-9-ol, 6'-methoxy-, Monohydrochloride, (8alpha,9r)-
35. Quinine Hydrochloride (1:1)
36. Schembl184367
37. Chembl588046
38. Dtxsid7044213
39. Tcmdc-123484
40. Tcmdc-125479
41. Cinchonan-9-ol, 6'-methoxy-, Hydrochloride, (8alpha,9r)-
42. Cinchonan-9-ol, 6'-methoxy-, Hydrochloride, (8.alpha.,9r)-
43. Cinchonan-9-ol, 6'-methoxy-, Monohydrochloride, (8-alpha,9r)-
44. Quinine Hydrochloride [fhfi]
45. Mfcd00078498
46. Akos016002029
47. Cinchonan-9-ol, 6'-methoxy-, Monohydrochloride, Dihydrate, (8alpha,9r)-
48. Quinine Hydrochloride [who-dd]
49. 6'-methoxycinchonan-9-ol Hydrochloride
50. As-70722
51. Quinine Monohydrochloride Anhydrous
52. Quinine Hydrochloride Anhydrous [mi]
53. A51181
54. Q27268091
55. (8.alpha.,9r)-6'-methoxycinchonan-9-ol Hydrochloride
56. Cinchonan-9-ol, 6'-methoxy-, Hydrochloride (1:?), (8alpha,9r)-
57. (r)-(6-methoxyquinolin-4-yl)((2s,4s,5r)-5-vinylquinuclidin-2-yl)methanol Hydrochloride
58. (r)-[(2s,4s,5r)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl](6-methoxyquinolin-4-yl)methanol Hydrochloride
| Molecular Weight | 360.9 g/mol |
|---|---|
| Molecular Formula | C20H25ClN2O2 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 4 |
| Exact Mass | 360.1604557 g/mol |
| Monoisotopic Mass | 360.1604557 g/mol |
| Topological Polar Surface Area | 45.6 Ų |
| Heavy Atom Count | 25 |
| Formal Charge | 0 |
| Complexity | 457 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Analgesics, Non-Narcotic
A subclass of analgesic agents that typically do not bind to OPIOID RECEPTORS and are not addictive. Many non-narcotic analgesics are offered as NONPRESCRIPTION DRUGS. (See all compounds classified as Analgesics, Non-Narcotic.)
Muscle Relaxants, Central
A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358) (See all compounds classified as Muscle Relaxants, Central.)
Antimalarials
Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
20
PharmaCompass offers a list of Quinine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Quinine Hydrochloride manufacturer or Quinine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Quinine Hydrochloride manufacturer or Quinine Hydrochloride supplier.
PharmaCompass also assists you with knowing the Quinine Hydrochloride API Price utilized in the formulation of products. Quinine Hydrochloride API Price is not always fixed or binding as the Quinine Hydrochloride Price is obtained through a variety of data sources. The Quinine Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Quinbisul manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Quinbisul, including repackagers and relabelers. The FDA regulates Quinbisul manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Quinbisul API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Quinbisul manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Quinbisul supplier is an individual or a company that provides Quinbisul active pharmaceutical ingredient (API) or Quinbisul finished formulations upon request. The Quinbisul suppliers may include Quinbisul API manufacturers, exporters, distributors and traders.
click here to find a list of Quinbisul suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Quinbisul DMF (Drug Master File) is a document detailing the whole manufacturing process of Quinbisul active pharmaceutical ingredient (API) in detail. Different forms of Quinbisul DMFs exist exist since differing nations have different regulations, such as Quinbisul USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Quinbisul DMF submitted to regulatory agencies in the US is known as a USDMF. Quinbisul USDMF includes data on Quinbisul's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Quinbisul USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Quinbisul suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Quinbisul Drug Master File in Japan (Quinbisul JDMF) empowers Quinbisul API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Quinbisul JDMF during the approval evaluation for pharmaceutical products. At the time of Quinbisul JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Quinbisul suppliers with JDMF on PharmaCompass.
A Quinbisul CEP of the European Pharmacopoeia monograph is often referred to as a Quinbisul Certificate of Suitability (COS). The purpose of a Quinbisul CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Quinbisul EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Quinbisul to their clients by showing that a Quinbisul CEP has been issued for it. The manufacturer submits a Quinbisul CEP (COS) as part of the market authorization procedure, and it takes on the role of a Quinbisul CEP holder for the record. Additionally, the data presented in the Quinbisul CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Quinbisul DMF.
A Quinbisul CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Quinbisul CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Quinbisul suppliers with CEP (COS) on PharmaCompass.
A Quinbisul written confirmation (Quinbisul WC) is an official document issued by a regulatory agency to a Quinbisul manufacturer, verifying that the manufacturing facility of a Quinbisul active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Quinbisul APIs or Quinbisul finished pharmaceutical products to another nation, regulatory agencies frequently require a Quinbisul WC (written confirmation) as part of the regulatory process.
click here to find a list of Quinbisul suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Quinbisul as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Quinbisul API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Quinbisul as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Quinbisul and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Quinbisul NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Quinbisul suppliers with NDC on PharmaCompass.
Quinbisul Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Quinbisul GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Quinbisul GMP manufacturer or Quinbisul GMP API supplier for your needs.
A Quinbisul CoA (Certificate of Analysis) is a formal document that attests to Quinbisul's compliance with Quinbisul specifications and serves as a tool for batch-level quality control.
Quinbisul CoA mostly includes findings from lab analyses of a specific batch. For each Quinbisul CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Quinbisul may be tested according to a variety of international standards, such as European Pharmacopoeia (Quinbisul EP), Quinbisul JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Quinbisul USP).
